Asbestos

CASRN 1332-21-4

  • IRIS Summary (PDF) (15 pp, 129 K)
  • Status: Asbestos is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (15 pp, 129 K)
Not assessed under the IRIS Program.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (15 pp, 129 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (15 pp, 129 K) last updated: 09/26/1988

WOE Characterization Framework for WOE Characterization
A (Human carcinogen) Guidelines for Carcinogen Risk Assessment (US EPA, 1986)
Basis:
  • Observation of increased mortality and incidence of lung cancer, mesotheliomas and gastrointestinal cancer in occupationally exposed workers are consistent across investigators and study populations. Animal studies by inhalation in two strains of rats showed similar findings for lung cancer and mesotheliomas. Animal evidence for carcinogenicity via ingestion is limited (male rats fed intermediate-range chrysotile fibers; i.e., >10 um length, developed benign polyps), and epidemiologic data in this regard are inadequate.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (15 pp, 129 K)

Not Assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (15 pp, 129 K)

Inhalation Unit Risk: 2.3 x10 -1 per f/mL
Extrapolation Method: Additive risk of lung cancer and mesothelioma, using relative risk model for lung cancer and absolute risk model for mesothelioma
Tumor site(s): Respiratory
Tumor type(s): Lung cancer and mesothelioma (Selikoff et al., 1979; Peto et al., 1982; Seidman et al., 1979; Peto, 1980; Finkelstein, 1983)


You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.